Skip to main content
logo
Cyclerion Therapeutics, Inc. (CYCN)
NASDAQ: CYCN · Real-Time Price · USD
1.240
+0.070 (5.98%)
Feb 11, 2026, 4:00 PM EST - Market closed

Cyclerion Therapeutics Revenue

Cyclerion Therapeutics had revenue of $875.00K in the quarter ending September 30, 2025, with 351.03% growth. This brings the company's revenue in the last twelve months to $2.86M, up 1,371.65% year-over-year. In the year 2024, Cyclerion Therapeutics had annual revenue of $2.00M.

Revenue (ttm)
$2.86M
Revenue Growth
+1,371.65%
P/S Ratio
1.22
Revenue / Employee
$2,855,000
Employees
1
Market Cap
4.72M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20242.00M--
Dec 31, 2023---
Dec 31, 2022297.00K-3.65M-92.47%
Dec 31, 20213.94M1.65M71.69%
Dec 31, 20202.30M-2.21M-49.06%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
GeoVax Labs3.35M
Xenetic Biosciences2.86M
Aprea Therapeutics488.24K
Abpro Holdings183.00K
VivoSim Labs140.00K
Bio Green Med Solution81.00K
Revenue Rankings

CYCN News

More News